Cardiotoxicity Associated with Immune Checkpoint Inhibitors
S. Minegishi, N. Horita, et al.
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
LRP1B mutation is associated with tumor immune microenvironment and progression-free survival in lung adenocarcinoma treated with immune checkpoint inhibitors
Z. He, W. Feng, et al.
Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy
Y. Xiao, J. Chen, et al.
Hypertension associated with serotonin reuptake inhibitors: A new analysis in the WHO pharmacovigilance database and examination of dose-dependency
B. Chrétien, A. Rabiaza, et al.
Better adherence to guidelines among psychiatrists providing pharmacological therapy is associated with longer work hours in patients with schizophrenia
S. Ito, K. Ohi, et al.
